Search results
PTC Stock Surges 41% in a Year: Will the Rally Continue?
Zacks· 5 days agoFree Report) is continuing its upward trajectory, with a gain of 41% in the past year compared with the S&P 500 composite and sub-industry’s growth of 29.2% and 35.7%, respectively.
PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug
Zacks via Yahoo Finance· 7 days agoPTC Therapeutics (PTCT) gains 21% on May 20 after the EC decided against adopting the negative CHMP...
The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar...
Zacks via Yahoo Finance· 4 days agoStocks recently featured in the blog include: Biogen BIIB, Ionis Pharmaceuticals IONS, GSK plc GSK, ...
Tech Tuesdays: IBM’s Latest Gen AI Research
WWD· 7 days agoPTC also leveled up its platform for improved integration and better efficiencies.
IRS Updates PTC and ITC Domestic Content Bonus Guidance | JD Supra
JD Supra· 5 days agoIn the original guidance issued by the IRS on May 12, 2023 (Notice 2023-38, the “...
Union Pacific No. 4014 can now run on its own - Trains
Trains.com· 4 days agoWhile Big Boy has operated with a LeaPTC system since 2021, says a UP statement, the new equipment...
3 High Performing Indian Dividend Stocks Yielding Up To 6.4%
Simply Wall St. via Yahoo Finance· 11 hours agoThe Indian market has shown robust performance recently, with a 1.7% increase in the last week and...
Tech Tuesdays: IBM’s Latest Gen AI Research
Footwear News· 7 days agoIn this week’s tech news, platform integration and generative AI (gen AI) are top of mind. PTC and MakerSights Aim to Revolutionize Retail In a...
The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar...
Zacks· 4 days ago(PTCT Quick QuotePTCT - Free Report) and Larimar Therapeutics, Inc. (LRMR Quick QuoteLRMR - Free Report...
Insider Sale: Director Jerome Zeldis Sells 20,000 Shares of PTC
Guru Focus· 3 days agoDirector Jerome Zeldis of PTC Therapeutics Inc (PTCT, Financial) executed a sale of 20,000 shares of the company on May 22, 2024, according to a recent SEC Filing. Following ...